A 2021 retrospective observational study cited in the PMC literature directly compared BPC-157 alone versus BPC-157 combined with TB-500 in a knee injection protocol and found the combination to be associated with improved outcomes providing the first head-to-head comparative observation of the two compounds used together versus independently
GSH depletion causes ferroptosis in RPE cells To evaluate the mechanism of cell death in GSH-depleted cells, we treated RPE cells with various cell death pathway inhibitors including ferroptosis inhibitors ferrostatin-1 (Fer-1, 8 M), liproxstatin-1 (Lip-1, 600 nM), iron chelator deferoxamine (DFO, 80 M), pan-caspase inhibitor z-VAD-fmk (30 M) to inhibit apoptosis, autophagy inhibitor 3-methyladenine (3-MA, 10 mM), and lysosomal inhibitor bafilomycin A1 (Baf-A1, 75 nM)
FSP1/CoQ10 and its related antioxidant system The ferroptosis suppressor protein 1 (FSP1)/coenzyme Q10 (CoQ10) pathway is another efficient endogenous antioxidant system independent of GPX4/GSH system, that critically regulates cellular sensitivity toward ferroptosis
This peptide formulation was created to investigate the potential additive or synergistic benefits of combining three distinct mechanisms of action into a single research tool
